Anti-Asthmatic Agents
"Anti-Asthmatic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are used to treat asthma.
Descriptor ID |
D018927
|
MeSH Number(s) |
D27.505.954.796.050
|
Concept/Terms |
Anti-Asthmatic Agents- Anti-Asthmatic Agents
- Agents, Anti-Asthmatic
- Anti Asthmatic Agents
- Anti-Asthmatics
- Anti Asthmatics
- Antiasthmatic Drugs
- Drugs, Antiasthmatic
- Antiasthmatics
- Anti-Asthmatic Drugs
- Anti Asthmatic Drugs
- Drugs, Anti-Asthmatic
- Antiasthmatic Agents
- Agents, Antiasthmatic
|
Below are MeSH descriptors whose meaning is more general than "Anti-Asthmatic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Asthmatic Agents".
This graph shows the total number of publications written about "Anti-Asthmatic Agents" by people in this website by year, and whether "Anti-Asthmatic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 2 | 1 | 3 | 1997 | 4 | 0 | 4 | 1998 | 4 | 0 | 4 | 1999 | 4 | 1 | 5 | 2000 | 3 | 2 | 5 | 2001 | 2 | 0 | 2 | 2002 | 6 | 0 | 6 | 2003 | 9 | 1 | 10 | 2004 | 6 | 3 | 9 | 2005 | 5 | 5 | 10 | 2006 | 7 | 3 | 10 | 2007 | 5 | 3 | 8 | 2008 | 7 | 8 | 15 | 2009 | 5 | 4 | 9 | 2010 | 6 | 4 | 10 | 2011 | 7 | 5 | 12 | 2012 | 3 | 6 | 9 | 2013 | 7 | 2 | 9 | 2014 | 3 | 2 | 5 | 2015 | 10 | 3 | 13 | 2016 | 12 | 7 | 19 | 2017 | 12 | 4 | 16 | 2018 | 13 | 5 | 18 | 2019 | 10 | 0 | 10 | 2020 | 14 | 3 | 17 | 2021 | 13 | 1 | 14 | 2022 | 12 | 0 | 12 | 2023 | 9 | 0 | 9 | 2024 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Asthmatic Agents" by people in Profiles.
-
Tanverdi MS, Navanandan N, Brackman S, Huber L, Leonard J, Mistry RD. Impact of a discharge prescription for dexamethasone on outcomes of children treated in the emergency department for acute asthma exacerbations. J Asthma. 2024 Jun; 61(6):584-593.
-
Stempel DA, Szefler SJ. Is the assessment of asthma treatment efficacy sufficiently comprehensive? J Allergy Clin Immunol. 2024 Mar; 153(3):629-636.
-
Mosnaim GS, Hoyte FCL, Safioti G, Brown R, Hill TD, Li T, Sagalovich K, DePietro M, Wechsler ME. Effectiveness of a Maintenance and Reliever Digihaler System in Asthma: 24-Week Randomized Study (CONNECT2). J Allergy Clin Immunol Pract. 2024 02; 12(2):385-395.e4.
-
Karamanis A, Bleacher H, DeSanto K. Effectiveness of ICS/LABA Compared With SABA as Relief Medications for Asthma. Am Fam Physician. 2023 11; 108(5):515-516.
-
Thomas D, McDonald VM, Stevens S, Harvey ES, Baraket M, Bardin P, Bowden JJ, Bowler S, Chien J, Chung LP, Gillman A, Hew M, Hodge S, James A, Jenkins C, Katelaris CH, Katsoulotos GP, Langton D, Lee J, Marks G, Peters M, Radhakrishna N, Reynolds PN, Rimmer J, Sivakumaran P, Upham JW, Wark P, Yang IA, Gibson PG. Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients. Allergy. 2024 02; 79(2):384-392.
-
Pavord ID, Hoyte FCL, Lindsley AW, Ambrose CS, Spahn JD, Roseti SL, Cook B, Griffiths JM, Hellqvist ?, Martin N, Llanos JP, Martin N, Colice G, Corren J. Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR). Ann Allergy Asthma Immunol. 2023 11; 131(5):587-597.e3.
-
Chen W, Tran TN, Sadatsafavi M, Murray R, Wong NCB, Ali N, Ariti C, Bulathsinhala L, Gil EG, FitzGerald JM, Alacqua M, Al-Ahmad M, Altraja A, Al-Lehebi R, Bhutani M, Bjermer L, Bjerrum AS, Bourdin A, von B?low A, Busby J, Canonica GW, Carter V, Christoff GC, Cosio BG, Costello RW, Fonseca JA, Gibson PG, Yoo KH, Heaney LG, Heffler E, Hew M, Hilberg O, Hoyte F, Iwanaga T, Jackson DJ, Jones RC, Koh MS, Kuna P, Larenas-Linnemann D, Lehmann S, Lehtim?ki L, Lyu J, Mahboub B, Maspero J, Menzies-Gow AN, Newell A, Sirena C, Papadopoulos NG, Papaioannou AI, Perez-de-Llano L, Perng Steve DW, Peters M, Pfeffer PE, Porsbjerg CM, Popov TA, Rhee CK, Salvi S, Taill? C, Taube C, Torres-Duque CA, Ulrik C, Ra SW, Wang E, Wechsler ME, Price DB. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry. J Allergy Clin Immunol Pract. 2023 09; 11(9):2732-2747.
-
Pfeffer PE, Ali N, Murray R, Ulrik C, Tran TN, Maspero J, Peters M, Christoff GC, Sadatsafavi M, Torres-Duque CA, Altraja A, Lehtim?ki L, Papadopoulos NG, Salvi S, Costello RW, Cushen B, Heffler E, Iwanaga T, Al-Ahmad M, Larenas-Linnemann D, Kuna P, Fonseca JA, Al-Lehebi R, Rhee CK, Perez-de-Llano L, Perng Steve DW, Mahboub B, Wang E, Goh C, Lyu J, Newell A, Alacqua M, Belevskiy AS, Bhutani M, Bjermer L, Bjornsdottir U, Bourdin A, Bulow AV, Busby J, Canonica GW, Cosio BG, Dorscheid DR, Mu?oz-Esquerre M, FitzGerald JM, Gil EG, Gibson PG, Heaney LG, Hew M, Hilberg O, Hoyte F, Jackson DJ, Koh MS, Ko HB, Lee JH, Lehmann S, Chaves Loureiro C, L??v?ksd?ttir D, Menzies-Gow AN, Mitchell P, Papaioannou AI, Popov TA, Porsbjerg CM, Salameh L, Sirena C, Taill? C, Taube C, Tohda Y, Wechsler ME, Price DB. Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both. Allergy. 2023 07; 78(7):1934-1948.
-
Bleecker ER, Meyers DA, Billheimer D, Li H, Newbold P, Kwiatek J, Hirsch I, Katial R, Li X. Clinical Implications of Longitudinal Blood Eosinophil Counts in Patients With Severe Asthma. J Allergy Clin Immunol Pract. 2023 06; 11(6):1805-1813.
-
Anderson WC, Banzon TM, Chawes B, Papadopoulos NG, Phipatanakul W, Szefler SJ. Factors to Consider in Prescribing Asthma Biologic Therapies to Children. J Allergy Clin Immunol Pract. 2023 03; 11(3):693-701.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|